Alex King

Alex King

Three-decade investment professional with experience in US public stocks, leveraged buyouts and venture capital. CEO of Cestrian Capital Research, Inc.

Market On Open, Sunday 11 January

Homework!

Market On Open, Friday 9 January

1-800-NO-SCOTUS?

Pfizer ( PFE ) – Q3 2025 Review

The Stock That Fell To Earth

Vertiv Holdings (VRT) Q3 FY12/25 Earnings Review

Still Racking Up The Wins

Market On Open, Thursday 8 January

Wider, Deeper Coverage Starts Today

Metals On Open, Wednesday 7 January

BTFD x WW3

In Pursuit Of Entropy: The Trade Desk ($TTD) Q3 Earnings Review

What Next For The Worst Performing Stock Of 2025?

Market On Open, Tuesday 6 January

Goldilocks?

Q: Is There A Generational Opportunity In Biotech Stocks?

Biotech 2026 = Tech 2023?

Regeneron (REGN) – Q3 2025 Review

Eyeing A Breakout?